Search clinical trials for: restless leg syndrome

Total 293052 results

Brigham and Women's Hospital
Federal Emergency Management Agency

Completed

Fire Fighter Fatigue Management Program: Operation Fight Fatigue

Insomnia | Obstructive Sleep Apnea | Shift-Work Sleep Disorder | Impaired Driving | Restless Leg Syndrome

United States
Brigham and Women's Hospital

Completed

Sleep Disorders Management, Health and Safety in Police

Sleep Apnea, Obstructive | Restless Legs Syndrome | Sleep Initiation and Maintenance Disorders | Sleep Disorders | Sleep Disorders, Circadian Rhythm

United States
Astellas Pharma Inc

Completed

Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

Restless Legs Syndrome

Japan
Children's Hospitals and Clinics of Minnesota

Completed

Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome

Iron Deficiency | Restless Leg Syndrome

United States
Boehringer Ingelheim

Completed

Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)

Restless Legs Syndrome
Pharmacosmos A/S
Laboratory Corporation of America; BioStata

Withdrawn

IV Iron Treatment of Restless Legs Syndrome

Restless Legs Syndrome
Walter Reed National Military Medical Center

Withdrawn

Vasculaire Leg Compression Device for the Treatment of Restless Legs Syndrome - A Prospective Clinical Study

Ekbom Syndrome | Restless Legs Syndrome, | Restless Legs,

United States
Cleveland Sleep Research Center
XenoPort, Inc.; YRT Limited

Unknown

Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs Syndrome

Restless Legs Syndrome

United States
King Abdulaziz University
King AbdulAziz City for Science and Technology

Unknown

Vitamin D in the Treatment of Primary Restless Legs Syndrome

Restless Legs Syndrome
Lake Erie Research Institute

Completed

RESTIFFIC™ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome (RESTIFFIC)

Restless Leg Syndrome

United States
Brigham and Women's Hospital
GlaxoSmithKline

Completed

Altered Brain GABA and Glutamate in Restless Legs Syndrome (RLS)

Restless Legs Syndrome

United States
University of Zurich
Vifor Pharma

Completed

Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy

Iron Deficiency Anemia | Restless Leg Syndrome

Switzerland
UCB BIOSCIENCES GmbH

Completed

A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis

Restless Legs Syndrome | End-Stage Renal Disease

United States, Austria, Finland, France, Germany, Italy
Astellas Pharma Inc

Completed

ASP8825 - Study in Patients With Restless Legs Syndrome

Restless Legs Syndrome

Japan
Acibadem University

Unknown

Apelin in Willis Ekbom Disease

Restless Legs Syndrome
UCB Pharma

Completed

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms

Restless Legs Syndrome

Germany
UCB Pharma

Completed

Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)

Restless Legs Syndrome

Germany, Spain, Austria
UCB Pharma

Completed

An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome

Restless Legs Syndrome

United States
Boehringer Ingelheim

Completed

Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)

Restless Legs Syndrome
UCB Pharma

Completed

Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects

Idiopathic Restless Legs Syndrome

Germany
UCB Pharma

Completed

Rotigotine Restless Legs Syndrome Dose Finding Trial

Idiopathic Restless Leg Syndrome

Germany
UCB Pharma

Completed

Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

Restless Legs Syndrome

United States
Boehringer Ingelheim

Completed

Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)

Restless Legs Syndrome
UCB Pharma

Completed

Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome

Restless Legs Syndrome

Germany
UCB Pharma

Completed

A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

Restless Legs Syndrome

Germany
Boehringer Ingelheim

Completed

Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome

Restless Legs Syndrome

Japan
UCB Pharma

Completed

Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS) (RESTORE)

Restless Legs Syndrome

United States
Boehringer Ingelheim

Completed

A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.

Idiopathic Restless Legs Syndrome

Japan
Boehringer Ingelheim

Completed

Non-interventional Observational Study on the Influence of Pramipexole on Sensory Symptoms of Restless Legs Syndrome (RLS)

Restless Legs Syndrome

Germany
Boehringer Ingelheim

Completed

Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)

Restless Legs Syndrome

Austria, Belgium, Finland, Germany, Ireland, Netherlands, Slovakia, Spain, United Kingdom
Azienda Socio Sanitaria Territoriale degli Spedali...
Ospedale San Raffaele

Unknown

Impact of Adjuvant Treatment With Aromatase Inhibitor on Sleep Disturbances in Postmenopausal Women With Endocrine Responsive Early Breast Cancer

Endocrine Responsive Early Breast Cancer

Italy
Boehringer Ingelheim

Completed

Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)

Restless Legs Syndrome

China
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)

Idiopathic Restless Legs Syndrome

Japan
Boehringer Ingelheim

Completed

Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome

Restless Legs Syndrome

Austria
Otsuka Pharmaceutical Co., Ltd.

Completed

A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients

Idiopathic Restless Legs Syndrome

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome (RLS)

Idiopathic Restless Legs Syndrome
Boehringer Ingelheim

Completed

Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS

Restless Legs Syndrome

Korea, Republic of
All India Institute of Medical Sciences, New Delhi

Unknown

Sleep Quality in Pregnancy and Its Impact on Pregnancy Outcomes

Obstructive Sleep Apnea | Infant, Very Low Birth Weight | Pregnancy Induced Hypertension | High-Risk Pregnancy | Restless Leg Syndrome

India
Tel-Aviv Sourasky Medical Center

Unknown

Targeting Dopamine Therapy in RLS

Restless Legs Syndrome

Israel
Heidi Moretti, MS, RD
University of Arkansas; Saint Patrick Hospital

Completed

Biotin Deficiency and Restless Legs Syndrome

Restless Legs Syndrome | End Stage Renal Disease
Boehringer Ingelheim

Completed

A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)

Restless Legs Syndrome

Germany
Boehringer Ingelheim

Completed

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

Restless Legs Syndrome

United States
Boehringer Ingelheim

Completed

Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)

Restless Legs Syndrome

Finland
Boehringer Ingelheim

Completed

Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life

Restless Legs Syndrome

Germany
Boehringer Ingelheim

Completed

Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome

Restless Legs Syndrome

Switzerland
Boehringer Ingelheim

Completed

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

Restless Legs Syndrome

United States
Boehringer Ingelheim

Completed

Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome

Restless Legs Syndrome

Japan
Boehringer Ingelheim

Completed

Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients

Restless Legs Syndrome

Germany, Austria, Netherlands, Norway, Sweden
Rambam Health Care Campus

Completed

Restless Legs Syndrome in Stroke Patients

Stroke | Restless Legs Syndrome | Transient Ischemic Attack
Beddit.com Ltd

Completed

Validation Study for an Unobtrusive Online Sleep Measurement System

Apnea | Restless Legs Syndrome | Sleep Fragmentation

Finland

3

Subscribe